Long-Term Debt Volume: Sionna Therapeutics, Inc. (SION)

Graphic logo of Sionna Pharma (SION)

Sionna Therapeutics Inc (SION) generates revenue based on the market launch of targeted therapies, specifically CFTR protein correctors for cystic fibrosis. This chart of the current share price reflects the 0.01 indicator. The business relies on a unique scientific foundation and patent protection, creating an insurmountable barrier to entry. Stable demand for innovation renders the asset defensive, as the company's development remains isolated from global macroeconomic fluctuations.

Company Long-Term Debt: Sionna Pharma (SION) for 02/08/2025 - 11/01/2026

Summary analytical data breakdowns for Sionna Pharma (SION)

- market price and analyst price targets:
Stock Price sionnatx.com|SION - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Sionna Therapeutics|SION - Enterprise Value
- balance sheet equity data:
Net Assets per Share Sionna Therapeutics|SION - Company Book Value|Market-to-Book Ratio sionnatx.com|SION - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Ratio Sionna Therapeutics Inc|SION - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Sionna Corp|SION - Company Aggregate Debts|Debts to Book Capitalization Sionna Therapeutics|SION - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Sionna Therapeutics|Intermediate Liquidity Ratio sionnatx.com
- company profitability and valuation multiples indicators:
SION - Net Profit
Summary company analytics:SION (sionnatx.com)
Flagship merchandise of sionnatx.com

Sionna Therapeutics Inc (SION) seeks dominance in the cystic fibrosis therapy niche through the development of a high-tech R&D pipeline. Analyzing the company's long-term financial obligations, an investor assesses the aggregate of loans with maturities exceeding one year, which allows for determining the stability of the capital structure when financing clinical trials and evaluating the debt load risk within the horizon of the long-term market consensus.

Competitor analysis for Sionna Therapeutics Inc

Company Long-Term Debts Tempus Labs TEM|QGEN - Company Long-Term Debt|Long-Term Debt Volume Ionis Pharmaceuticals, Inc. IONS|RGEN: Company Long-Term Debts|RNA - Long-Term Debt Volume|Company Long-Term Debt CRISPR Therapeutics AG|Long-Term Debt genedx.com WGS|Company Long-Term Debt Ultragenyx (RARE)|Beam Therapeutics Inc - Company Long-Term Indebtedness|Company Long-Term Debt Sarepta Therapeutics Inc SRPT|TWST: Company Long-Term Indebtedness|10x Genomics, Inc. - Company Long-Term Debts|NTLA - Company Long-Term Debts|STOK (Stoke Therapeutics, Inc.) - Company Long-Term Liabilities|BioLife Solutions Inc - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities WVE|MAZE (Maze Therapeutics Corp) - Amount of Long-Term Liabilities|Company Long-Term Debts PRME|TSHA (tayshagtx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts QURE (uniQure)|MeiraGTx Holdings (MGTX) - Long-Term Debt|RGNX - Company Long-Term Debt|Company Long-Term Loans and Borrowings SLDB (Solid Corp)|OCGN: Company Long-Term Debts|pacb.com (PACB) - Company Long-Term Debts|Company Long-Term Debt Benitec Biopharma|Design Therapeutics Inc - Long-Term Liabilities|Company Long-Term Debts RCKT|FDMT - Long-Term Debt|Lexeo Therapeutics, Inc. - Company Long-Term Liabilities|Company Long-Term Debts Korro Bio Inc. KRRO|EDIT: Company Long-Term Liabilities|Silence Therapeutics PLC - Amount of Long-Term Liabilities|PRQR: Company Long-Term Debts|CDXS - Long-Term Debt Volume|SGMO (Sangamo Therapeutics) - Company Long-Term Debts|Company Long-Term Liabilities Nautilus Biotechnology Inc (NAUT)|Company Long-Term Debt Metagenomi (MGX)|Long-Term Debt Volume Precision BioSciences Inc.|Generation Bio - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings BOLD|Exicure Corp - Company Long-Term Debts|Long-Term Debt Volume Imunon, Inc. IMNN|phiopharma.com (PHIO) - Company Long-Term Debt|Company Long-Term Indebtedness MBIO|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Bionano (BNGO)|Company Long-Term Debt Applied DNA Sciences (APDN)|Long-Term Debt Volume bluebirdbio.com|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Long-Term Debt Volume Omega Therapeutics Inc (OMGA)|OMIC - Company Long-Term Debt|Long-Term Debt Regulus|Syros Pharmaceuticals (SYRS) - Company Long-Term Debt|Company Long-Term Indebtedness TBIO|TCON (TRACON Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Indebtedness UBX (Unity Biotechnology Inc.)